All systems operational
Q2 2026

Phenotyping and symptom diagnostic accuracy in unproven gastroesophageal reflux disease (GERD): An experience from Saudi GI Motility Labs

Mohammed A. Alzahrani · Ibrahim M. Almanjahi · Abdullah A. Alquzi · Abdulaziz H. Alamri · Abdullah M. Shahrani · Mohammed S. Mukharrib · Saad A. AlQahtani · Eman A. Almahjani · Aishah M. Alahmari · Sarah H. Asiri · Mohra S. Alqahtani · Alanoud I. Asiri · Bushra Y. Alsharif · Bader S. Alahmari · Osamah H. Abu Hawi · Mushabbab S. Hammad · Khalid Y. Nabrawi · Ali M. Alamari · Abdullah A. Al-Shahrani · Abdullah M. Alshehri · Abdullah M. Algarni
10.4103/sjg.sjg_43_26 385 Views 0 Citations
0
Citations
385
Views
Abstract

Abstract

Background:
The recent Saudi Gastroenterology Association (SGA) clinical care pathway for gastroesophageal reflux disease (GERD) recommends objective physiologic testing in patients with persistent reflux symptoms and normal endoscopy. This study aimed to phenotype patients with unproven GERD using 24-h multichannel intraluminal impedance–pH (MII-pH) monitoring and high-resolution manometry (HRM), and to evaluate the diagnostic utility of reflux symptoms.


Methods:
In this retrospective cohort study, adult patients with reflux-like symptoms and either normal endoscopy or Los Angeles grade A esophagitis underwent off-proton pump inhibitor MII-pH monitoring and HRM, between July 2020 and September 2025. GERD phenotypes were classified as non-erosive reflux disease (NERD), reflux hypersensitivity (RH), or functional heartburn (FH) according to the Lyon Consensus v2.0 and SGA clinical care pathway guidelines. Manometric findings were interpreted using the Chicago Classification criteria. The sensitivity and specificity of typical and extra-esophageal symptoms for identifying NERD were assessed.


Results:
A total of 117 patients were included (median age 39 years; 53.85% male). Phenotyping identified 27.35% as NERD, 47.86% as RH, and 24.79% as FH. Symptom profiles overlapped across groups. Median acid exposure time and mean nocturnal baseline impedance showed expected physiologic gradients, with the highest acid burden and lowest impedance in NERD. Abnormal esophageal motility was present in 34.2%, most commonly ineffective esophageal motility. Heartburn and regurgitation were highly sensitive (93.75% and 90.62%, respectively), but poorly specific (8.24% and 15.29%, respectively) for NERD, whereas cough and laryngitis were highly specific (88.24% and 84.71%, respectively), but minimally sensitive (6.25% and 9.38%, respectively).


Conclusion:
RH and FH predominate in patients with unproven GERD. Symptom assessment alone is insufficient for accurate diagnosis, although typical symptoms retain screening value due to their high sensitivity. These findings highlight the need for integrated physiologic testing to guide precise phenotyping and individualized management.

Cite this Article (APA)
Mohammed, A. A., Ibrahim, M. A., Abdullah, A. A., Abdulaziz, H. A., Abdullah, M. S., Mohammed, S. M., Saad, A. A., Eman, A. A., Aishah, M. A., Sarah, H. A., Mohra, S. A., Alanoud, I. A., Bushra, Y. A., Bader, S. A., Osamah, H. A. H., Mushabbab, S. H., Khalid, Y. N., Ali, M. A., Abdullah, A. A., Abdullah, M. A., Abdullah, M. A. (2026). Phenotyping and symptom diagnostic accuracy in unproven gastroesophageal reflux disease (GERD): An experience from Saudi GI Motility Labs. Saudi Journal of Gastroenterology. https://doi.org/10.4103/sjg.sjg_43_26
Related Papers
The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi …
Saleh A. Alqahtani; Faisal Abaalkhail; Saad Alghamdi; Khalid Bzeizi; Waleed K. A · 2024
20
cites
397
CEBPB dampens the cuproptosis sensitivity of colorectal cancer cells by facilitating the PI3K/AKT/mT…
Tianchen Huang; Yong Zhang; Yachao Wu; Xiaodong Han; Lei Li; Zhipeng Guo; Kan Li · 2024
15
cites
398
SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024
Abdullah S. Alghamdi; Hamdan Alghamdi; Haleema A. Alserehi; Mohammed A. Babatin; · 2024
11
cites
396
The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real w…
Nahla Azzam; Othman Alharbi; Mansour Altuwaijri; Yazed Alruthia; Heba Alfarhan; · 2024
9
cites
396
The Saudi Gastroenterology Association consensus on the clinical care pathway for the diagnosis and …
Mohammed A. Alzahrani; Abdullah M. Alqaraawi; Saeed R. Alzubide; Ehab Abufarhane · 2024
7
cites
395
Access
View Full Text via DOI
Published in
ISSN 1319-3767
Quartile Q2
AMS Score 93
Field Medicine & Health Sciences
Publisher Wolters Kluwer / Saudi Gastroentero
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2026
Language English
Added 23 Jul 2026